Skip to main content

5 Result(s)

within Won-Sik Lee Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Open Access

    Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects

    Venadaparib is a next-generation poly(ADP-ribose) polymerase inhibitor under development for treating gastric cancer. This study aimed to evaluate the effects of food and ethnicity on the pharmacokinetics (PKs...

    Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh… in Investigational New Drugs (2024)

    Download PDF (1389 KB) View Article

  2. No Access

    Article

    TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin

    The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer.

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2009)

  3. No Access

    Article

    Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

    Since a weekly administration of paclitaxel has demonstrated a sustained efficacy and more favorable toxicity profile than a 3-weekly administration for various solid tumors, the present study was conducted to...

    Jong Gwang Kim, Sang Kyun Sohn, Hong Suk Song… in Cancer Chemotherapy and Pharmacology (2007)

  4. No Access

    Article

    Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

    The present study was conducted to evaluate the safety and efficacy of alemtuzumab plus CHOP chemotherapy for patients with peripheral T-cell lymphomas (PTCLs).

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2007)

  5. No Access

    Article

    CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

    Objective: The present study evaluated the feasibility of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus etoposide and gemcitabine (CHOP-EG) as front-line chemothe...

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2006)